DEC 27, 2016 12:03 PM PST

How Cancer Spreads Even Before a Tumor Develops

WRITTEN BY: Xuan Pham

In a small fraction of cancer cases, doctors can’t trace the origin of the metastatic cancer because, mysteriously, there’s no original tumor to be found. How can cancer spread before it is even formed? Fortunately, scientists are beginning to unveil the mechanism behind this invisible cancer spread.

By studying both animal models and human samples of breast cancers, researchers from Mount Sinai found that early cancer can spread silently even when a tumor’s not yet present. The mechanism behind this subversive attack comes from the simultaneous activation of an oncogene (HER2) and the deactivation of a tumor suppressor gene (p38), they report.

"This research provides insight into the mechanisms of early cancer spread and may shed light into unexplained phenomena -- among them, why as many as 5 percent of cancer patients worldwide have cancer metastases but no original tumor, and most importantly, why it is so difficult to treat cancer that has spread," said Julio A. Aguirre-Ghiso, the study’s senior author.

In 2 to 3 percent of women diagnosed with ductal carcinoma in situ (DCIS), a primary tumor is never found. But yet, these women succumb to cancer metastasis. This suggests that some early cancerous lesions are enough to disseminate the spread of cancer cells to other parts of the body.

The team found that activation of HER2 and deactivation of p38 creates an opportunity for cells to mobilize and spread through the mammary network. Two signaling pathways implicated are the epithelial to mesenchymal transition signaling pathway and the progesterone receptor signaling pathway.

"Biologically, this new model of early metastasis challenges everything we thought we knew about how cancer spreads and forms metastasis. It feels like we are going to have to adjust our ideas about the subject of metastasis," said Aguirre-Ghiso. "Our hope is that these findings will reshape the way we think about how metastasis should be treated."

"We were able to use organoids in three-dimensional cultures, and high resolution imaging directly in the live animal models to actually see these cells enter the bloodstream from the mammary tree and travel to the lung, the bone marrow, and other places," he says. "We hadn't thought about oncogenes and tumor suppressors in this way before. This is a new function for these pathways."

Beyond breast cancer, the study has implications for other cancer types too. In particular, pancreatic cancer and melanoma, two of the deadliest cancer types, may also have the same mechanism of silent metastasis. "While our findings add a whole new level of complexity to the understanding of cancer, they also add energy to our efforts to finally solve the big issue in cancer -- stop the metastasis that kills patients," said Aguirre-Ghiso.

Additional sources: Mount Sinai Health System

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JUL 31, 2018
Cancer
JUL 31, 2018
Can Medicine Prevent Cisplatin-associated Hearing Loss for Pediatric Cancer Patients?
Researchers have determined that sodium thiosulfate's antioxidant properties can prevent hearing loss in pediatric cancer patients being treated with Cisplatin....
OCT 06, 2018
Genetics & Genomics
OCT 06, 2018
Genetic Mutation Linked to Increased Pancreatic Cancer Risk in Women
In a first, researchers have found a genetic mutation that has a sex-specific effect on pancreatic cancer risk....
OCT 08, 2018
Immunology
OCT 08, 2018
Natural Killer Cells to Aid in Cancer Therapy
Researchers utilize nanoparticles to stimulate NK cells that induce tumor cells to express PDL1, a protein involved in immune response messaging...
NOV 12, 2018
Cancer
NOV 12, 2018
Targeted radiation therapy may provide new hope to children with difficult-to-treat liver cancer
Primary malignant liver tumors are rare in children with an occurrence rate of 1-2% of all childhood cancers. Radical surgical resection of the liver which means the removal of part of the li...
DEC 04, 2018
Immunology
DEC 04, 2018
Why is Skin Cancer so Elusive?
A pathway involved in skin cancer reveals a potential immunotherapy target...
DEC 06, 2018
Drug Discovery
DEC 06, 2018
Repurposing Cancer Drugs For HPV Treatment
Drug repurposing is transforming the health care world. The idea that old, previously-- FDA approved drugs could be altered and to be used again for the tr...
Loading Comments...